Topline Shares of Wegovy and Ozempic maker Novo Nordisk fell more than 21% Tuesday, pacing what would be the stock’s largest plunge since the 1980s after the Danish pharmaceutical firm cut its full-year guidance for sales and profit, as growth for its obesity and weight loss treatments are expected to slow in the U.S. The Danish firm said weaker Wegovy …
Read More »
Novo Nordisk lowered its sales forecast for obesity drug Wegovy, citing competition from compounded versions. Scott Olson/Getty Images hide caption toggle caption Scott Olson/Getty Images Novo Nordisk’s shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug. Before the markets opened, the company announced that sales of its obesity medicine, Wegovy, are expected …
Read More »Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times Novo Nordisk Shares Plummet as Competition Weighs on Sales The Wall Street Journal Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance CNBC Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding NPR Wegovy maker Novo’s profit warning triggers $70 billion share rout Reuters Source …
Read More »Novo Nordisk Shares Plummet as Competition Weighs on Sales The Wall Street Journal Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times Novo Nordisk outgoing CEO blames compounded GLP-1s for decline in 2025 outlook Yahoo Finance Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance CNBC Novo Stock (NVO) Tumbles. Ozempic, Wegovy Maker …
Read More »SoFi, UnitedHealth, Novo Nordisk, UPS, Boeing, Sarepta, Whirlpool, and More Movers Barron’s Stocks making the biggest moves premarket: Novo Nordisk, Whirlpool, Sarepta Therapeutics and more CNBC Procter & Gamble, Sarepta Therapeutics, Cadence Design Systems TradingView Source link
Read More »Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again Reuters Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance CNBC Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short Bloomberg.com Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO Yahoo Finance Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic MarketWatch Source link
Read More »Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic MarketWatch Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance CNBC Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook Yahoo Finance Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short Bloomberg Novo Nordisk Stock Plummets After Ozempic, Wegovy Maker Cuts U.S. Outlook Barron’s Source link
Read More »
Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its blockbuster Wegovy obesity drug in the key U.S. market. The company also named Maziar Mike …
Read More »